Eterna Therapeutics Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eterna Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q2 2024.
  • Eterna Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $423K, a 97.7% increase year-over-year.
  • Eterna Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.04M, a 41.2% decline year-over-year.
  • Eterna Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.24M, a 57.7% decline from 2022.
  • Eterna Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.94M, a 43.9% decline from 2021.
  • Eterna Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.24M, a 5653% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.04M $423K +$209K +97.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $835K $282K -$407K -59.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.24M $165K -$232K -58.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $1.47M $174K -$302K -63.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.78M $214K -$665K -75.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2.44M $689K -$494K -41.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $2.94M $397K -$1.79M -81.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $4.72M $476K -$1.25M -72.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $5.97M $879K -$275K -23.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $6.25M $1.18M +$1.01M +600% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.24M $2.18M +$2.16M +9475% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $3.07M $1.73M +$1.71M +7505% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.37M $1.15M +$1.13M +4976% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $237K $169K +$146K +643% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $91K $22.8K Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 $22.7K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $22.7K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $22.7K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2015 $99K +$47K +90.4% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-08
Q1 2014 $52K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.